| CAPS | community adjustment profile system |
|---|---|
| caps | capsule |
| IBN | inhibitory burst neuron |
|---|---|
| FLU | Fluoxetine |
| FLX | Fluoxetine |
| CAPS | Capsaicin |
| CAPS | Cardiac Arrhythmia Pilot Study |
| RNA caps | Compounds with the general structure 7-methyl-5'-guanosine triphosphate-5'-x which modify the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear rnas. These compounds, which are positively charged, protect the above specified rnas at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA cap analogs), which lack the positive charge, inhibit the initiation of protein synthesis. (12 Dec 1998) |
|---|---|
| dental caps | <veterinary> Deciduous cheek teeth in the horse which remain attached to erupting permanent teeth. (05 Mar 2000) |
| fluoxetine | <chemical> The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Pharmacological action: antidepressive agents, second-generation, serotonin uptake inhibitors. Chemical name: Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)- (12 Dec 1998) |
| fluoxetine hydrochloride | Benzenepropanamine, N-methyl-gamma-[4-(trifluoromethyl)-phenoxy]-;an oral antidepressant chemically unrelated to other antidepressants; prevents serotonin reuptake. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
ÀιÙÀÌ¿À³ÝÇ÷ç¿Á¼¼Æ¾Ä¸½¶ - »õâ
|
ÀιÙÀÌ¿À³Ý |
A79100421 | Fluoxetine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|